Company / Operating Cash Flow per Share
ImmunityBio, Inc. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.36
FY2025
5-year range
-$0.87 / -$0.36
FY2021-FY2025
Trend
+38.7%
vs FY2024
Sector context
#91 of 212
Health Care
What the data says
At $-0.36, ImmunityBio, Inc.'s operating cash flow per share ranks #91 of 212 in the Health Care sector. Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-1.92 in FY2019 to $-0.07 in FY2016.
Based on SEC 10-K filings.
-0.36 in FY2025.
Improved from $-0.87 to $-0.36 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#91 of 212 in Health CareTop 43% of 212This company -$0.36 Sector average $5.28
▼
-106.8% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 38.7% year-over-year.
- Ranks #91 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2016.
- Lowest operating cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -7.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.36 | +38.7% |
| FY2024 | -$0.58 | +33.0% |
| FY2023 | -$0.87 | -2.5% |
| FY2022 | -$0.85 | -113.2% |
| FY2021 | -$0.40 | +77.2% |
| FY2020 | -$1.74 | +9.3% |
| FY2019 | -$1.92 | -293.8% |
| FY2018 | -$0.49 | -58.2% |
| FY2017 | -$0.31 | -363.2% |
| FY2016 | -$0.07 | +99.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026